Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Therapy in VLBW Infants at Risk for CLD
NCT00011362Phase 3Completed
- Sponsor
- NICHD Neonatal Research Network
- Start
- Sep 1992
- Primary completion
- Jan 1994
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in bronchopulmonary dysplasia (BPD) (2 arms), sponsored by NICHD Neonatal Research Network. Primary endpoint: Number of days from randomization to ventilator independence. Started Sep 1992; status: completed.
02
Drugs
dexamethasone
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT00011362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00011362.